emisgroup
Emis Group Plc (LON:EMIS), the AIM-listed medical software provider has released annual results that have come in ahead of the market’s expectations.Revenues grew by 6% to £168.2m and Earnings per share rose 10% to 56.1%.The group raised its dividend for the 11 year in a row, lifting the pay-out by 10% to 35.2p per share for the year.Q4 2021 hedge fund letters, conferences and more Chief Executive Andy Thorburn hailed a “positive year of good growth and margin performance” and described EMIS as “well paced with products directly aligned to market need”. He said the group was “building momentum...
ValueWalk
Emis Group Plc (LON:EMIS) has today reported that trading results for 2021 will be slightly ahead of the top end of consensus expectations after a second half which saw a more normal pattern of trading in its core GP software markets and double-digit growth for its EMIS Enterprise division.Q4 2021 hedge fund letters, conferences and more EMIS Enterprise has benefited from its Pinnacle software, which has played a key role in organising the Covid vaccination effort, whilst EMIS Health has seen software accounting for a higher proportion of revenues as GP surgeries have returned to more normal w...
ValueWalk
Emis Group Plc (LON:EMIS) reported first half revenues of £83.5m, up 7% year-on-year. That reflects particularly strong growth in EMIS Enterprise, following the introduction of a national vaccination system to record and communicate vaccination status across the NHS and to individuals. Q2 2021 hedge fund letters, conferences and more Operating profits rose 13% to £20.0m, although cash conversion declined as the benefits of delayed VAT payments during the pandemic unwound. The group announced an interim dividend of 17.6%, up 10% year-on-year. EMIS shares fell 1.0% in early trading. Impressive G...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら